Therapeutic potential of convalescent plasma and hyperimmune immunoglobulins against SARS-CoV-2 BQ.1, BQ.1.1, and XBB variants


Lorenza Bellusci, Hana Golding, and Surender Khurana Journal of Clinical Investigation Published 2023 – More infoView PDF  Convalescent plasma (CP) and hyperimmune intravenous immunoglobulins (IVIGs) are routinely used to treat patients with COVID-19. SARS-CoV-2 Omicron variants continue to evolve, generating multiple sublineages with increased transmissibility and antibody-escape mutations (1, 2). Several Omicron lineages that are currently circulating (BA.4, BA.5, […]

Vaccine Makers “Deceptive” Booster Campaign


Wall Street Journal January 23, 2023 Wall Street Journal editorial board member Allysia Finley has taken a flamethrower to vaccine makers over their “deceptive” campaign for bivalent Covid boosters, and slams several federal agencies for taking “the unprecedented step of ordering vaccine makers to produce them and recommending them without data supporting their safety or […]

Bivalent Covid-19 Vaccines — A Cautionary Tale .


List of authors. Paul A. Offit, M.Dt of authors. Paul A. Offit, M.D New England Journal of Medicine January 23, 2023 in Wuhan, China. Two months later, the original strain of SARS-CoV-2, called the Wuhan-1 or ancestral strain, was isolated and sequenced. It was now possible to make a vaccine. All the vaccines, including the […]

Bivalent Covid-19 Vaccines — A Cautionary Tale.


List of authors. Paul A. Offit, M.D New England Journal of Medicine January 23, 2023 in Wuhan, China. Two months later, the original strain of SARS-CoV-2, called the Wuhan-1 or ancestral strain, was isolated and sequenced. It was now possible to make a vaccine. All the vaccines, including the mRNA vaccines made by Pfizer–BioNTech and […]

What COVID-19 variants are going around in November 2022?


Authors: Nebraska Medicine November 1, 2022 There are currently more than 37,000 cases reported in the United States per day, with test positivity of 8.6%. When test positivity is above 5%, transmission is considered uncontrolled. There are more than 340 deaths per day, and hospitalizations have increased 8% over the last two weeks.  What COVID-19 variant […]

Yet Another Curveball in the COVID Mutation Nightmare


Authors: David Axe September 6, 2022 The Daily Beast When the pharmaceutical industry scrambled to develop the first COVID vaccines back in 2020, it made sense that developers focused on the part of the virus that allows it to grab onto and infect our cells: the spike proteins. The best vaccines contain a piece of the spike, or […]

Unraveling the Interplay of Omicron, Reinfections, and Long Covid


Authors:  Liz Szabo AUGUST 26, 2022 KHN The latest covid-19 surge, caused by a shifting mix of quickly evolving omicron subvariants, appears to be waning, with cases and hospitalizations beginning to fall. Like past covid waves, this one will leave a lingering imprint in the form of long covid, an ill-defined catchall term for a set […]

Omicron is considered a milder coronavirus, but scientists aren’t so sure


Authors: Melissa Healy August 13, 2022 la times For more than two years, Cathy Baron and Sara Alicia Costa managed to duck the coronavirus. But despite their being fully vaccinated and boosted, the Omicron variant finally caught them. Baron is an actress and dance instructor who lives in Santa Monica. Costa is an architect in Austin, […]

Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection


Authors: Julie Boucau, Ph.D. Caitlin Marino, B.S. Ragon Institute, Cambridge, MA James Regan, B.S. Brigham and Women’s Hospital, Boston, MA Rockib Uddin, B.S.Massachusetts General Hospital, Boston, MA Manish C. Choudhary, Ph.D.James P. Flynn, B.S. Brigham and Women’s Hospital, Boston, MA Geoffrey Chen, B.A.Ashley M. Stuckwisch, B.S. Josh Mathews, A.B. May Y. Liew, B.A. Arshdeep Singh, […]

Natural Immunity From Omicron Strong Against Virus Subvariants: Study


Authors: Zachary Stieber via The Epoch Times, UL 18, 2022 The protection afforded by surviving COVID-19 was strong against the latest virus subvariants, including the one currently dominant in the United States, scientists in Qatar found. People who were infected with Omicron, a variant of SARS-CoV-2, had 76.1 percent protection against symptomatic reinfection from BA.4 and BA.5 […]